Abstract
Introduction: Human combined immunodeficiency (CID) was first reported more than 50 years ago. It is now known that CID can be caused in humans by mutations of many different genes and the likelihood is that there are other causes yet to be discovered. Regardless of the underlying defect infants with this syndrome are lymphopenic and have profound deficiencies of T and B cell numbers and function. Recognition of the characteristic lymphopenia can result in early diagnosiseven at birth. Flow cytometric studies have shown that there are unique lymphocyte phenotypes for the various genetic forms of CID.
Materials and Methods: Fourteen-four patients who fulfill the criteria of CID, flow cytometric analysis were performed by using Beckman Coulter, Epics XL -MCL; System II software; Miami, Florida, USA. Monoclonal antibodies, anti-CD3, anti- CD4, anti-CD8, anti-CD16, anti-CD56 and anti-CD19 were also purchased from Beckman Coulter. Absolute lymphocyte numbers of patient and control groups were compared statistically.Results and
Discussion: Affected infants all presented with common problems such as oral moniliasis, diarrheas, severe pneumonias and failure to thrive in the first few months of life. Our CID group which is amongst the largest groups presented from Turkey, showed the clinical features necessary to suspect from this rare syndrome and the distribution of the CID phenotypes in Turkey. The 44 CID patients seen in 7 years, 95% showed ALC<3000/mm while only one patient of the control group with the similar infections had ALS<3000/mm . This study demonstrated the potential of ALC to diagnose CID routinely under 1 year of age showing severe infections. We suggest that if the ALC of <3000/mm is seen, efforts should be made for the early diagnosis of CID
Keywords: Combined Immunodeficiency
References
- Hong R, Clement L T, Gatti R A, Kirkpatrick C H. Disorders of the T- 3 cell system.In: Stiehm E R. ed. Immunologic Disorders in Infants and Children.4th ed. Philadelphia: WB Saunders, 1996: 339-408. 3
- Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004; 22:625-655.
- Notarangelo L, Casanova JL, Conley ME, Chapel H, Fisher A, Pock 1, Roijman c, Seger R, Geha RS; International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117:883-896. 3
- Verbsky JW, Grossman WJ. Cellular and Genetic Basis of Primary Immune Deficiencies. Pediatr Clin Narth Am 2006; 53:649-684.
- Buckley RH, Schiff RІ, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts J L, Puck JM. Human severe combined immunodeficiency:Genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997;130:378-387. 3
- Fischer A, Cavazzana-Calvo M, De Saint Basile G, De Villartay JP, Di Santo JP, Hivroz C, Rieux-Laucat F, Le Deist F. Naturlly Occuring Primary Deficiencies of the Immune System. Annu Rev Immunol 1997;15:93-124.
- WHO Scientific Group. Primary Immunodeficiency Diseases: Report of a WHO Scientific Group.Clin Exp Immunol 1995;99:1-24.
- Rosen FS. Severe combined immunodeficiency: A pediatric emergency. J Pediatr 1997;130:345-346.
- Hague RA, Rassam S, Morgan G, Cant AJ. Early diagnosis of severe combined immunodeficiencies. Arch Dis Child 1994; 70:260-263.
- Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint- Basile G, Durandy A, Griscelli C Fisher A. Severe combined immunodeficiency: A retrospective single center study of clinical presentation and outcome in 117 patients J Pediatr 1993;123:564- 572.